Breakthrough in Alzheimer’s Disease Treatment: Alzheimer Society of Ontario Applauds US Approval of…
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario welcomes today’s US FDA decision to grant full approval to lecanemab (brand name: Leqembi), a disease-modifying therapy for Alzheimer’s disease. This marks the…